Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by iRhythm

iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm Technologies Announces Third Quarter 2024 Financial Results
From iRhythm
Via GlobeNewswire
Tickers IRTC
Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 Meeting
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm Technologies Announces Results of GUARD-AF Trial
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm Technologies to Participate in Upcoming Investor Conferences in September
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm Technologies Announces Chief Financial Officer Transition
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm Technologies Announces Second Quarter 2024 Financial Results
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm Technologies to Report Second Quarter 2024 Financial Results on August 1, 2024
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm Technologies Achieves Significant Operational Milestone with Launch of Initial Phase of Manufacturing Automation
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm Technologies to Present at the 2024 Truist Securities MedTech Conference
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm Technologies to Present at the William Blair 44th Annual Growth Stock Conference
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm Technologies Announces First Quarter 2024 Financial Results
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers’ $86.25 Million Option to Purchase Additional Notes
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm Announces Proposed Offering of $450.0 Million of Convertible Senior Notes
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm collaborates with Epic to streamline access to Zio® service and drive more seamless connectivity between clinicians and patients
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm Technologies Announces Fourth Quarter and Full Year 2023 Financial Results
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm Technologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm Technologies Shares Preliminary Fourth Quarter 2023 Highlights and Business Update at the 42nd Annual J.P. Morgan Healthcare Conference
From iRhythm
Via GlobeNewswire
Tickers IRTC
Largest Ever Real-World Evidence Study of Ambulatory Cardiac Monitoring Demonstrates Clinical Superiority of iRhythm's Zio Long-Term Continuous Monitoring Service
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm Technologies Receives European Union’s CE Marking Under Medical Device Regulation (EU MDR) for its Zio® monitor and ZEUS System
From iRhythm
Via GlobeNewswire
Tickers IRTC
New Research Presented at American Heart Association’s 2023 Scientific Sessions Demonstrates Performance of Continuous Monitoring ECG Data for Improved Prediction of Heart Failure Hospitalization
From iRhythm
Via GlobeNewswire
Tickers IRTC
iRhythm Launches Next Generation Zio Monitor and Enhanced Zio Service: Its Smallest, Lightest and Thinnest Cardiac Monitor
From iRhythm
Via GlobeNewswire
Tickers IRTC
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.